Drug Type TCR-T Cell therapy |
Synonyms TCR-T T cell targeting KRAS G12V mutation, NW-301V |
Target |
Action modulators |
Mechanism KRAS G12V modulators(GTPase KRas G12V modulators) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colorectal Cancer | Phase 1 | China | 31 Mar 2024 | |
Pancreatic Cancer | Phase 1 | China | 31 Mar 2024 |